Skip to main content
. 2020 Jul 7;9:e58227. doi: 10.7554/eLife.58227

Table 2. Temporal analysis of the EHR clinical notes for the week preceding PCR testing (i.e. day −7 to day −1), leading up to the day of PCR testing (day 0) in COVIDpos and COVIDneg patients.

Temporal enrichment for each symptom is quantified using the ratio of COVIDpos patient proportion over the COVIDneg patient proportion for each day. The patient proportions in the rows labeled ‘Positive’ and ‘Negative’ represent the fraction of COVIDpos (n = 2,317) and COVIDneg (n = 74,850) patients with the specified symptom on each day. Symptoms with p-value<1E-10 are highlighted in green and 1E-10 < p value<1E-03 in gray.

Symptom COVID-19 (N = 77167) Day = −7 Day = −6 Day = −5 Day = −4 Day = −3 Day = −2 Day = −1
Altered or diminished sense of taste or smell Positive (n = 2317) 4.75E-03 3.88E-03 3.45E-03 2.59E-03 1.73E-03 0.00E+00 4.75E-03
 Negative (n = 74850) 1.07E-04 4.01E-05 1.07E-04 1.07E-04 9.35E-05 2.27E-04 9.75E-04
 Ratio (Positive/Negative) 44.42 96.91 32.30 24.23 18.46 0.00 4.87
p-value 1.14E-44 2.24E-48 3.17E-28 2.35E-18 8.94E-11 4.68E-01 5.85E-08
Cough Positive 2.55E-02 2.29E-02 1.90E-02 1.64E-02 1.38E-02 8.63E-03 7.94E-02
 Negative 4.88E-03 5.30E-03 5.21E-03 5.33E-03 5.73E-03 8.40E-03 8.71E-02
 Ratio (Positive/Negative) 5.22 4.31 3.64 3.08 2.41 1.03 0.91
p-value 8.42E-40 7.44E-28 2.43E-18 2.68E-12 6.68E-07 9.06E-01 1.95E-01
Diarrhea Positive 8.20E-03 7.77E-03 6.04E-03 4.32E-03 4.75E-03 2.59E-03 2.68E-02
 Negative 3.70E-03 4.26E-03 4.58E-03 4.09E-03 4.58E-03 5.61E-03 3.78E-02
 Ratio (Positive/Negative) 2.22 1.82 1.32 1.06 1.04 0.46 0.71
p-value 5.59E-04 1.17E-02 3.08E-01 8.66E-01 9.08E-01 5.32E-02 5.81E-03
Fever/chills Positive 2.42E-02 2.20E-02 1.94E-02 1.68E-02 1.34E-02 6.47E-03 7.90E-02
 Negative 3.39E-03 3.74E-03 3.90E-03 4.42E-03 4.61E-03 6.77E-03 7.48E-02
 Ratio (Positive/Negative) 7.12 5.88 4.98 3.81 2.90 0.96 1.06
p-value 1.15E-54 4.31E-40 6.52E-29 1.64E-17 2.36E-09 8.62E-01 4.52E-01
Respiratory Difficulty Positive 2.24E-02 2.11E-02 1.81E-02 1.55E-02 1.25E-02 8.20E-03 5.35E-02
 Negative 5.06E-03 5.70E-03 5.81E-03 5.87E-03 6.16E-03 8.66E-03 7.65E-02
 Ratio (Positive/Negative) 4.43 3.71 3.12 2.65 2.03 0.95 0.70
p-value 2.07E-28 8.72E-21 9.41E-14 4.56E-09 1.48E-04 8.15E-01 3.89E-05
Change in appetite/intake Positive 1.73E-03 1.73E-03 1.73E-03 5.18E-03 4.32E-03 5.61E-03 1.86E-02
 Negative 1.30E-03 1.36E-03 1.34E-03 1.39E-03 1.40E-03 1.91E-03 1.35E-02
 Ratio (Positive/Negative) 1.33 1.27 1.29 3.73 3.08 2.94 1.37
p-value 5.72E-01 6.42E-01 6.14E-01 3.53E-06 3.43E-04 9.41E-05 4.03E-02
Myalgia/Arthralgia Positive 8.20E-03 9.06E-03 7.77E-03 6.47E-03 5.61E-03 2.59E-03 3.84E-02
 Negative 2.24E-03 3.05E-03 3.17E-03 2.99E-03 2.87E-03 3.99E-03 2.72E-02
 Ratio (Positive/Negative) 3.65 2.98 2.45 2.16 1.95 0.65 1.41
p-value 9.33E-09 4.91E-07 1.44E-04 2.98E-03 1.68E-02 2.88E-01 1.18E-03
Congestion Positive 6.91E-03 6.47E-03 5.18E-03 3.45E-03 5.18E-03 2.16E-03 1.94E-02
 Negative 1.95E-03 2.38E-03 1.98E-03 2.36E-03 2.18E-03 2.95E-03 2.63E-02
 Ratio (Positive/Negative) 3.54 2.72 2.62 1.46 2.38 0.73 0.74
p-value 2.87E-07 1.01E-04 8.47E-04 2.92E-01 2.78E-03 4.86E-01 4.07E-02
Rhinitis Positive 7.77E-03 6.04E-03 4.32E-03 3.02E-03 2.16E-03 8.63E-04 1.38E-02
 Negative 1.23E-03 1.42E-03 1.32E-03 1.36E-03 1.38E-03 2.04E-03 1.96E-02
 Ratio (Positive/Negative) 6.32 4.27 3.26 2.22 1.57 0.42 0.70
p-value 2.08E-16 2.61E-08 1.58E-04 3.63E-02 3.21E-01 2.11E-01 4.59E-02